Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 06-2015 | 06-2014 | 06-2013 | 06-2012 | |
| Sales | 4,769 | 4,606 | 4,219 | 4,525 | 5,071 |
| Cost of Goods | 4,640 | 4,439 | 4,416 | 4,375 | 4,368 |
| Gross Profit | 129 | 167 | -197 | 150 | 703 |
| Operating Expenses | 5,851 | 4,943 | 4,807 | 4,593 | 4,669 |
| Operating Income | -5,082 | -4,337 | -4,588 | -4,067 | -3,598 |
| Interest Expense | 1 | 2 | 1 | 0 | 62 |
| Other Income | 372 | 658 | -1,370 | 211 | 171 |
| Pre-tax Income | -4,711 | -3,681 | -5,959 | -3,857 | -3,489 |
| Net Income Continuous | -4,711 | -3,681 | -5,959 | -3,857 | -3,489 |
| Net Income | $-4,711 | $-3,681 | $-5,959 | $-3,857 | $-3,489 |
| EPS Basic Total Ops | -0.90 | -0.70 | -1.60 | -1.10 | -1.20 |
| EPS Basic Continuous Ops | -0.86 | -0.67 | -1.40 | -1.12 | -1.22 |
| EPS Diluted Total Ops | -0.90 | -0.70 | -1.60 | -1.10 | -1.20 |
| EPS Diluted Continuous Ops | -0.86 | -0.67 | -1.40 | -1.12 | -1.22 |
| EBITDA(a) | $-5,067 | $-3,761 | $-3,798 | $-3,229 | $-2,612 |